Crossmark

Conformational dynamics is key to understanding loss-of-function of NQO1 cancer-associated polymorphisms and its correction by pharmacological ligands

Crossref DOI link: https://doi.org/10.1038/srep20331

Published Online: 2016-02-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Medina-Carmona, Encarnación

Palomino-Morales, Rogelio J.

Fuchs, Julian E.

Padín-Gonzalez, Esperanza

Mesa-Torres, Noel

Salido, Eduardo

Timson, David J.

Pey, Angel L.
License Information

Text and Data Mining valid from 2016-02-03

Version of Record valid from 2016-02-03
More Information

Article History

Received: 7 October 2015

Accepted: 30 December 2015

First Online: 3 February 2016

Change Date: 4 March 2016

Change Type: Update

Change Details: A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has been fixed in the paper.

Competing interests

: The authors declare no competing financial interests.

Updates are available Erratum dated 2016-03-04

Click to view Erratum: https://doi.org/10.1038/srep21939